Cisapride系消化道运动赋活调整药。其特点是几无多巴胺拮抗作用,作用部位为食道至大肠的消化道。临床上具有食道运动亢进,下端食道括约肌压力上升,促进胃排空和胃内容物移行,结肠运动亢进等作用。 6个月以上经常性便秘患者,98例口服本品,每次1片(5 mg),113例口服本品每次2片,每日3次,共给药4周。结果表明, Cisapride Department of gastrointestinal motility adjustment drugs. It is characterized by several dopamine antagonism, the role of the site of the esophagus to the large intestine of the digestive tract. Clinically with esophageal hyperkinensis, lower esophageal sphincter pressure rise, and promote gastric emptying and gastric contents migration, colon hyperfunction and so on. Six patients with recurrent constipation more than 6 months, 98 cases of oral administration of the product, each one (5 mg), 113 cases of oral administration of this product 2 tablets, 3 times a day for a total of 4 weeks. The results show,